本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corcept医疗

83.71
+0.59000.71%
盘后83.710.00000.00%19:36 EDT
成交量:76.79万
成交额:6,422.77万
市值:89.87亿
市盈率:239.17
高:84.27
开:83.18
低:82.13
收:83.12
52周最高:91.00
52周最低:28.66
股本:1.07亿
流通股本:8,687.53万
量比:0.72
换手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):0.3500
每股收益(LYR):0.8200
净资产收益率:7.17%
总资产收益率:-0.62%
市净率:14.09
市盈率(LYR):102.09

数据加载中...

2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/21

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]